| 2026 |
| 06/25 | 4,000 | 4,080 | 3,985 | 4,035 | +0.88% | 121,900 | 1877億9690万 | +3.07% |
| 06/24 | 3,985 | 4,065 | 3,950 | 4,000 | -0.25% | 125,000 | 1861億6794万 | +2.25% |
| 06/23 | （IR情報）15:30 取締役及び執行役員に対する譲渡制限付株式としての自己株式処分に関するお知らせ |
| 06/23 | 3,940 | 4,025 | 3,935 | 4,010 | +1.78% | 95,900 | 1866億3335万 | +2.64% |
| 06/22 | 3,945 | 3,965 | 3,920 | 3,940 | -0.13% | 52,900 | 1833億7542万 | +1.13% |
| 06/19 | 3,970 | 4,010 | 3,935 | 3,945 | -0.63% | 184,900 | 1836億813万 | +1.6% |
| 06/18 | 3,920 | 4,000 | 3,900 | 3,970 | +1.79% | 152,200 | 1847億7168万 | +1.87% |
| 06/17 | （自社株買い）取締役会(2026年5月11日)での決議状況(取得期間2026年5月12日～2026年12月31日) |
| 06/17 | 3,990 | 3,995 | 3,890 | 3,900 | -2.01% | 150,100 | 1815億1374万 | -0.36% |
| 06/16 | 3,950 | 3,985 | 3,930 | 3,980 | +0.76% | 107,400 | 1852億3710万 | +1.22% |
| 06/15 | 3,910 | 3,990 | 3,910 | 3,950 | +1.15% | 118,300 | 1838億4084万 | +0.05% |
| 06/12 | 3,860 | 3,945 | 3,860 | 3,905 | +0.77% | 108,900 | 1817億4645万 | -1.59% |
| 06/11 | 3,860 | 3,875 | 3,810 | 3,875 | +0.39% | 108,300 | 1803億5019万 | -2.81% |
| 06/10 | 3,885 | 3,900 | 3,855 | 3,860 | 0% | 67,800 | 1796億5206万 | -3.64% |
| 06/09 | 3,820 | 3,895 | 3,800 | 3,860 | +1.05% | 139,200 | 1796億5206万 | -4.1% |
| 06/08 | 3,805 | 3,870 | 3,790 | 3,820 | +0.53% | 176,100 | 1777億9038万 | -5.56% |
| 06/05 | 3,750 | 3,865 | 3,745 | 3,800 | +1.47% | 155,700 | 1768億5954万 | -6.73% |
| 06/04 | 3,700 | 3,805 | 3,695 | 3,745 | -0.27% | 130,700 | 1742億9973万 | -8.75% |
| 06/03 | （IR情報）15:30 自己株式の取得状況に関するお知らせ |
| 06/03 | 3,695 | 3,765 | 3,635 | 3,755 | +0.54% | 98,200 | 1747億6515万 | -9.23% |
| 06/02 | 3,740 | 3,770 | 3,620 | 3,735 | -1.97% | 139,600 | 1738億3431万 | -10.41% |
| 06/01 | 3,855 | 3,880 | 3,795 | 3,810 | -2.06% | 125,200 | 1773億2496万 | -9.33% |
| 05/29 | 3,900 | 3,945 | 3,875 | 3,890 | +0.39% | 118,300 | 1810億4832万 | -8.17% |
| 05/28 | 4,010 | 4,050 | 3,875 | 3,875 | -3.37% | 128,400 | 1803億5019万 | -9.25% |
| 05/27 | （IR情報）15:30 急性骨髄性白血病治療薬オルタシデニブの国内製造販売承認申請のお知らせ |
| 05/27 | 4,010 | 4,055 | 3,965 | 4,010 | -0.12% | 112,500 | 1866億3335万 | -6.94% |
| 05/26 | 3,995 | 4,030 | 3,920 | 4,015 | -0.25% | 84,500 | 1868億6606万 | -7.49% |
| 05/25 | 4,145 | 4,175 | 3,975 | 4,025 | -3.13% | 232,800 | 1873億3148万 | -7.94% |
| 05/22 | 3,995 | 4,270 | 3,995 | 4,155 | +4.66% | 338,200 | 1933億8194万 | -5.57% |
| 05/21 | （IR情報）14:10 タブネオスの安全性確保のための注意喚起について |
| 05/21 | 3,920 | 3,975 | 3,890 | 3,970 | +2.58% | 205,900 | 1847億7168万 | -10.22% |
| 05/20 | 3,805 | 3,905 | 3,780 | 3,870 | +3.2% | 264,500 | 1801億1748万 | -13.05% |
| 05/19 | 3,580 | 3,765 | 3,500 | 3,750 | +4.02% | 720,300 | 1745億3244万 | -16.43% |
| 05/18 | 3,605 | 3,605 | 3,605 | 3,605 | -16.26% | 56,100 | 1677億8385万 | -20.4% |
| 05/15 | （IR情報）15:30 タブネオスの適正使用について |
| 05/15 | 4,360 | 4,400 | 4,280 | 4,305 | -1.94% | 99,100 | 2003億6324万 | -5.96% |
| 05/14 | 4,345 | 4,400 | 4,300 | 4,390 | +1.04% | 68,700 | 2043億1931万 | -4.54% |
| 05/13 | 4,340 | 4,420 | 4,315 | 4,345 | -0.69% | 118,400 | 2022億2492万 | -5.89% |
| 05/12 | （IR情報）16:00 2026年3月期決算説明会資料 |
| 05/12 | 4,400 | 4,440 | 4,230 | 4,375 | -1.91% | 229,800 | 2036億2118万 | -5.65% |
| 05/11 | （IR情報）16:30 2026年3月期決算補足資料 |
| 05/11 | （IR情報）16:30 2026年3月期決算短信〔日本基準〕(連結) |
| 05/11 | （IR情報）16:30 自己株式の取得及び自己株式の消却に関するお知らせ |
| 05/11 | 4,400 | 4,485 | 4,400 | 4,460 | +2.06% | 144,200 | 2075億7725万 | -4.19% |
| 05/08 | 4,360 | 4,405 | 4,320 | 4,370 | +0.23% | 134,700 | 2033億8847万 | -6.26% |
| 05/07 | 4,340 | 4,420 | 4,300 | 4,360 | +0.93% | 140,100 | 2029億2305万 | -6.72% |
| 05/01 | （IR情報）15:30 急性骨髄性白血病治療薬オルタシデニブのオリエントユーロファーマ社(台湾)への技術導出契約締結のお知らせ |
| 05/01 | 4,400 | 4,410 | 4,310 | 4,320 | -1.26% | 165,600 | 2010億6137万 | -7.91% |
| 04/30 | 4,510 | 4,520 | 4,335 | 4,375 | -3.74% | 196,200 | 2036億2118万 | -7.03% |
| 04/28 | 4,555 | 4,560 | 4,465 | 4,545 | -0.22% | 105,900 | 2115億3332万 | -3.65% |
| 04/27 | 4,505 | 4,595 | 4,505 | 4,555 | -0.22% | 63,800 | 2119億9874万 | -3.48% |
| 04/24 | （IR情報）17:00 代表取締役の異動に関するお知らせ |
| 04/24 | 4,520 | 4,580 | 4,520 | 4,565 | +0.55% | 70,300 | 2124億6416万 | -3.16% |
| 04/23 | 4,525 | 4,550 | 4,490 | 4,540 | -0.66% | 70,700 | 2113億61万 | -3.65% |
| 04/22 | 4,615 | 4,640 | 4,540 | 4,570 | -1.72% | 59,200 | 2126億9687万 | -3.08% |
| 04/21 | 4,730 | 4,735 | 4,640 | 4,650 | -2.11% | 50,700 | 2164億2023万 | -1.34% |
| 04/20 | 4,840 | 4,840 | 4,750 | 4,750 | -1.86% | 50,500 | 2210億7442万 | +0.91% |
| 04/17 | 4,785 | 4,850 | 4,785 | 4,840 | +1.15% | 58,500 | 2252億6320万 | +3.07% |
| 04/16 | 4,785 | 4,820 | 4,785 | 4,785 | -0.62% | 29,000 | 2227億339万 | +2.18% |
| 04/15 | 4,770 | 4,820 | 4,760 | 4,815 | +1.69% | 61,100 | 2240億9965万 | +2.95% |
| 04/14 | 4,700 | 4,760 | 4,690 | 4,735 | +0.74% | 60,700 | 2203億7629万 | +1.44% |
| 04/13 | 4,700 | 4,745 | 4,685 | 4,700 | 0% | 77,400 | 2187億4732万 | +0.82% |
| 04/10 | 4,745 | 4,790 | 4,670 | 4,700 | -1.47% | 69,700 | 2187億4732万 | +0.88% |
| 04/09 | 4,780 | 4,850 | 4,770 | 4,770 | -0.63% | 72,400 | 2220億526万 | +2.45% |
| 04/08 | 4,905 | 4,905 | 4,795 | 4,800 | -0.72% | 61,300 | 2234億152万 | +3.23% |
| 04/07 | 4,825 | 4,870 | 4,795 | 4,835 | +0.1% | 47,000 | 2250億3049万 | +4% |
| 04/06 | 4,895 | 4,925 | 4,825 | 4,830 | +0.1% | 65,400 | 2247億9778万 | +3.87% |
| 04/03 | 4,870 | 4,920 | 4,780 | 4,825 | -0.82% | 37,700 | 2245億6507万 | +3.61% |
| 04/02 | 4,905 | 4,940 | 4,860 | 4,865 | +1.14% | 117,300 | 2264億2675万 | +4.49% |
| 04/01 | 4,720 | 4,810 | 4,700 | 4,810 | +3.44% | 65,300 | 2238億6694万 | +3.29% |
| 03/31 | 4,640 | 4,685 | 4,615 | 4,650 | -0.43% | 77,800 | 2164億2023万 | -0.21% |
| 03/30 | 4,550 | 4,675 | 4,535 | 4,670 | -1.99% | 88,100 | 2173億5106万 | +0.13% |
| 03/27 | 4,705 | 4,765 | 4,695 | 4,765 | +1.38% | 95,500 | 2217億7255万 | +2.14% |
| 03/26 | 4,700 | 4,710 | 4,650 | 4,700 | +1.08% | 72,900 | 2187億4732万 | +0.84% |
| 03/25 | 4,670 | 4,705 | 4,635 | 4,650 | +1.09% | 95,300 | 2164億2023万 | -0.13% |
| 03/24 | 4,490 | 4,600 | 4,455 | 4,600 | +4.07% | 104,300 | 2140億9313万 | -1.16% |
| 03/23 | 4,475 | 4,480 | 4,390 | 4,420 | -2.54% | 69,600 | 2057億1557万 | -5.07% |
| 03/19 | （IR情報）10:00 子宮筋腫治療薬イセルティ錠100mg新発売のお知らせ |
| 03/19 | 4,565 | 4,595 | 4,505 | 4,535 | -1.41% | 183,800 | 2110億6790万 | -2.79% |
| 03/18 | 4,545 | 4,600 | 4,545 | 4,600 | +1.43% | 75,300 | 2140億9313万 | -1.5% |
| 03/17 | 4,505 | 4,550 | 4,500 | 4,535 | +1.23% | 42,800 | 2110億6790万 | -2.85% |
| 03/16 | 4,500 | 4,515 | 4,465 | 4,480 | -0.33% | 64,500 | 2085億809万 | -4.03% |
| 03/13 | 4,490 | 4,560 | 4,485 | 4,495 | -0.44% | 100,900 | 2092億622万 | -3.83% |
| 03/13 | （空売り報告）モルガン・スタンレーMUFG証券 227,986株（0.48%）-0.11%義務消失 |
| 03/12 | 4,620 | 4,630 | 4,505 | 4,515 | -2.27% | 70,300 | 2101億3706万 | -3.53% |
| 03/11 | 4,670 | 4,690 | 4,620 | 4,620 | +0.33% | 61,400 | 2150億2397万 | -1.41% |
| 03/10 | 4,650 | 4,660 | 4,580 | 4,605 | +0.55% | 80,200 | 2143億2584万 | -1.75% |
| 03/09 | 4,500 | 4,610 | 4,485 | 4,580 | -0.65% | 97,800 | 2131億6229万 | -2.26% |
| 03/06 | 4,590 | 4,650 | 4,555 | 4,610 | -0.75% | 126,300 | 2145億5855万 | -1.62% |
| 03/05 | 4,670 | 4,730 | 4,640 | 4,645 | +0.98% | 114,600 | 2161億8752万 | -0.79% |
| 03/04 | 4,650 | 4,720 | 4,575 | 4,600 | -3.97% | 108,200 | 2140億9313万 | -1.77% |
| 03/03 | 4,790 | 4,860 | 4,750 | 4,790 | -1.44% | 103,700 | 2229億3610万 | +2.18% |
| 03/03 | （空売り報告）モルガン・スタンレーMUFG証券 278,186株（0.59%）-0.02% |
| 03/02 | 4,935 | 4,955 | 4,850 | 4,860 | -2.99% | 76,200 | 2261億9404万 | +3.69% |
| 02/27 | （IR情報）15:30 従業員持株会に対する譲渡制限付株式としての自己株式処分に関するお知らせ |
| 02/27 | 4,840 | 5,040 | 4,830 | 5,010 | +4.59% | 213,600 | 2331億7534万 | +7.03% |
| 02/26 | 4,900 | 4,915 | 4,740 | 4,790 | -2.24% | 114,700 | 2229億3610万 | +2.64% |
| 02/25 | 4,840 | 4,900 | 4,805 | 4,900 | +0.72% | 101,000 | 2280億5572万 | +5.08% |
| 02/24 | 4,775 | 4,875 | 4,745 | 4,865 | +2.42% | 134,000 | 2264億2675万 | +4.53% |
| 02/24 | （空売り報告）モルガン・スタンレーMUFG証券 288,196株（0.61%）+0.09% |
| 02/20 | 4,690 | 4,790 | 4,670 | 4,750 | +0.96% | 134,600 | 2210億7442万 | +2.19% |
| 02/19 | 4,645 | 4,705 | 4,625 | 4,705 | +1.07% | 110,000 | 2189億8003万 | +1.25% |
| 02/19 | （空売り報告）モルガン・スタンレーMUFG証券 244,296株（0.52%）新規 |
| 02/18 | 4,640 | 4,695 | 4,630 | 4,655 | +1.42% | 74,900 | 2166億5294万 | +0.15% |
| 02/17 | 4,595 | 4,630 | 4,585 | 4,590 | -0.33% | 47,700 | 2136億2771万 | -1.35% |
| 02/16 | 4,660 | 4,660 | 4,565 | 4,605 | -0.97% | 63,800 | 2143億2584万 | -1.18% |
| 02/13 | 4,600 | 4,650 | 4,570 | 4,650 | +0.43% | 60,500 | 2164億2023万 | -0.34% |
| 02/12 | 4,660 | 4,675 | 4,615 | 4,630 | -0.64% | 72,800 | 2154億8939万 | -0.77% |
| 02/10 | 4,590 | 4,720 | 4,565 | 4,660 | +2.08% | 131,400 | 2168億8565万 | -0.11% |
| 02/09 | 4,600 | 4,600 | 4,545 | 4,565 | +0.77% | 66,600 | 2124億6416万 | -2.12% |
| 02/06 | 4,600 | 4,605 | 4,520 | 4,530 | -1.95% | 93,600 | 2108億3519万 | -2.94% |
| 02/05 | 4,690 | 4,705 | 4,620 | 4,620 | -0.65% | 114,800 | 2150億2397万 | -1.07% |
| 02/04 | 4,675 | 4,745 | 4,650 | 4,650 | -0.53% | 103,500 | 2164億2023万 | -0.41% |
| 02/03 | 4,625 | 4,725 | 4,605 | 4,675 | +1.08% | 88,800 | 2175億8377万 | +0.13% |
| 02/02 | 4,660 | 4,690 | 4,530 | 4,625 | +0.54% | 104,800 | 2152億5668万 | -0.92% |
| 01/30 | （IR情報）15:30 2026年3月期第3四半期決算補足資料 |
| 01/30 | （IR情報）15:30 配当予想の修正(創立80周年記念配当実施)に関するお知らせ |
| 01/30 | （IR情報）15:30 2026年3月期第3四半期決算短信〔日本基準〕(連結) |
| 01/30 | 4,595 | 4,645 | 4,540 | 4,600 | +0.88% | 80,200 | 2140億9313万 | -1.46% |
| 01/29 | 4,560 | 4,560 | 4,500 | 4,560 | +0.66% | 94,700 | 2122億3145万 | -2.29% |
| 01/28 | 4,600 | 4,605 | 4,510 | 4,530 | -2.79% | 65,400 | 2108億3519万 | -2.98% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
